Other

HRSA, Rural Tribal COVID-19 Response Program

The purpose is to provide maximum flexibility to assist tribes, tribal organizations, urban Indian health organizations, and health service providers to tribes to prevent, prepare for, and respond to the coronavirus and the evolving needs in rural communities. Specifically, this program will provide funding to assist tribes to engage in activities that may include, but are not limited to: establishing testing sites, purchasing test kits, implementing telehealth strategies/activities, purchasing personal protective equipment (PPE) and other supplies, and hiring and/or training health care providers and other health care personnel to provide care for COVID-19 patients.

Sponsor or Type
Deadline
May 6, 2020

American Lung Association COVID-19 and Emerging Respiratory Viruses Research Award

This award will fund clinical, basic, translational, and population health projects that seek to better understand the pathobiology and clinical implications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral infection that leads to the morbidity and mortality seen with COVID-19 : a new understanding of the basic biology of respiratory viruses that could lead to better treatment and prevention; development of novel therapeutics and vaccines; understanding host factors that alter response to these infections; understanding individual, regional, or social factors increasing or decreasing community spread of COVID-19 and other respiratory viruses; and case tracking and epidemiological approaches. Grants are up to $200,000 over two years; proposals are due by May 30, 2020.

Sponsor or Type
Deadline
May 30, 2020

FCC COVID-19 Telehealth Program

The COVID-19 Telehealth Program will provide $200 million in funding, appropriated by Congress as part of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, to help health care providers provide connected care services to patients at their homes or mobile locations in response to the novel Coronavirus 2019 disease (COVID-19) pandemic.  The Program will provide immediate support to eligible health care providers responding to the COVID-19 pandemic by fully funding their telecommunications services, information services, and devices necessary to provide critical connected care services until the program’s funds have been expended or the COVID-19 pandemic has ended.

Note that the COVID-19 Telehealth Program is limited to

nonprofit and public eligible health care providers that fall within the categories of health care providers in section 254(h)(7)(B) of the 1996 Act.  For more information, see Question 8 of the FAQs.

Sponsor or Type

Harrington Scholar Award for Coronavirus

HDI will select up to ten projects through the call for proposals and its current portfolio of drugs in development. Awarded projects will run for 12 months, with the possibility of extending the engagement. Read full press release announcing the call for proposals.

Award recipients will receive:

  • $150k guaranteed, with the potential to receive up to $1 million in charitable support.
  • Dedicated drug discovery and development support from Harrington Discovery Institute’s Therapeutics Development team (experienced pharma and business development team with a track record of bringing new drugs to market).
  • A personalized team of drug developers and project manager for every award recipient.
  • Select access to partners that range from non-profit, foundation, and public sector organizations to private drug development and investment companies.

Projects being sought:

  • Novel therapies that can target Coronavirus and its co-morbidities, such as impact on lungs and heart.
  • Broad-spectrum anti-viral therapies, particularly targeting respiratory viruses.
  • Next generation vaccines that may target new Corona strains, multiple Corona viruses or more than one type of virus.
  • Emergency countermeasures/prophylaxis strategies for first responders and emergency medical personnel to be administered either once or short term.
Sponsor or Type
Deadline
04/30/2020

UA Internal: Drachman Institute COVID-19 Community-Connected Seed Grants

COVID-19 has had medical, financial, and social impacts on our Arizona communities. These impacts have been uneven at best. For some community members, the consequences of isolation has been devastating. Recovery may be even more uneven and, in some ways, more complicated. To support researchers at UArizona to respond to questions related to the consequences and responses related to COVID-19 in our communities, the Drachman Institute will fund up to $10,000 in seed grants for 1 to 3 projects meeting the following criteria:

  • The project shall address one or more challenges created or revealed by COVID-19 within our Arizona communities impacted by the built environment. Built environment research examines the resource, health, economic, policy, and cultural impacts (and opportunities) related to the human constructed environment. This research also examines the processes, performance, and consequences of building this environment. See UArizona grand challenges within the built environment at https://restruct.arizona.edu .
  • At least one member of the project team must be from the College of Architecture Planning and Landscape Architecture
  • The project shall be completed between July 1, 2020 and June 30, 2021
Sponsor or Type

AWS Diagnostic Development Initiative (DDI)

The AWS Diagnostic Development Initiative (DDI) provides support for innovation in rapid and accurate patient testing for 2019 novel coronavirus (COVID-19), and other diagnostic solutions to mitigate future outbreaks. Although vaccine and treatment development research is generally funded by private foundations and government agencies, fast and reliable diagnostic techniques are slow to be developed. Accurate testing and diagnosis at point-of-care or regional locations for patients with COVID-19 is critical to early intervention and treatment. AWS is offering technical support and providing AWS promotional credits to support the use of AWS services to advance diagnostic research for selected institutions and companies.

Sponsor or Type

Microsoft AI for Health

This grant program provides Azure cloud and High-Performance Computing capabilities. Our team of AI for Health data science experts, whose mission is to improve the health of people and communities worldwide, is also open to collaborations with COVID-19 researchers as they tackle this critical challenge. More broadly, Microsoft’s research scientists across the world, spanning computer science, biology, medicine, and public health, will also be available to provide advice and collaborate per mutual interest.

Sponsor or Type
Deadline
06/15/2020

NEA CARES Act Grants

You must submit to Grants.gov by 04/22/2020 with full proposal due 05/04/2020. The Coronavirus Aid, Relief, and Economic Security (CARES) Act recognizes that the nonprofit arts industry is an important sector of America’s economy. The National Endowment for the Arts will award funds to nonprofit arts organizations across the country to help these entities and their employees endure the economic hardships caused by the forced closure of their operations due to the spread of COVID-19. As part of this important investment, the Arts Endowment has designed a plan to expedite the distribution of critical funds to the national, regional, state, and local levels to help retain as many jobs as possible, as quickly as possible. These funds are intended to help save jobs in the arts sector and keep the doors open to the thousands of organizations that add value to America’s economy and the creative life of our communities.

Sponsor or Type
Deadline
05/04/2020

The Global Fund COVID-19 Mechanism

The COVID-19 Response Mechanism authorizes funding of up to US$500 million and comes in addition to the grant flexibilities previously announced by the Global Fund.

With an initial allocation of US$500 million, the COVID-19 Response Mechanism will leverage the principle of country ownership and allow countries to request funding for control and containment, to mitigate the impact on HIV, TB and malaria and to support systems for health, including laboratory networks, supply chains, and community-led response. Details on the mechanism will be announced later. Learn more>

Sponsor or Type
Deadline
TBD

Providing Enhanced Medical Support for Patients with Primary Immunodeficiency Disorders

Pfizer is offering grants through a program entitled Providing Enhanced Medical Support for Patients with Primary Immunodeficiency Disorders. Individual projects of up to $250,000 will be considered for projects that leverage the utilization of innovative technology platforms for distant learning to reach the intended audience with a focus on patient outreach, medical support and telework. IHEs and health providers are eligible to apply. 

Sponsor or Type
Deadline
June 8, 2020